Ascend Wellness (AAWH) Stock Price, News & Analysis

Company Overview

Ascend Wellness Holdings is a U.S. cannabis company that cultivates, processes, and sells cannabis products in regulated state markets. Its business combines cultivation and manufacturing facilities with a network of retail dispensaries.

The company offers products including cannabis flower, edibles, concentrates, and vape products. Its portfolio includes brands such as Ozone and Simply Herb, alongside products from other suppliers sold through its retail stores.

Founded in 2018, Ascend has developed operations across markets including Illinois, Michigan, Ohio, Massachusetts, New Jersey, and Pennsylvania. Its activities and product availability are subject to the laws and regulations of each state.

Key Stats

• Today's Range: $0.33 to $0.37
• 50-Day Range: $0.35 to $0.65
• 52-Week Range: $0.33 to $1.20
• Volume: 261,816 shs
• Average Volume: 108,515 shs
• Market Capitalization: $71.04 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Ascend Wellness Stock Analysis - MarketRank™

Ascend Wellness scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Ascend Wellness has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Ascend Wellness has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Ascend Wellness are expected to decrease in the coming year, from ($0.28) to ($0.29) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Ascend Wellness is -0.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ascend Wellness is -0.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.03% of the float of Ascend Wellness has been sold short.

Short Interest Ratio / Days to Cover

Ascend Wellness has a short interest ratio ("days to cover") of 0.49, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ascend Wellness has recently decreased by 61.16%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ascend Wellness does not currently pay a dividend.

Dividend Growth

Ascend Wellness does not have a long track record of dividend growth.

News and Social Media

• Score: 1.7 / 5
• News Sentiment: -0.29

News Sentiment

Ascend Wellness has a news sentiment score of -0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Ascend Wellness this week, compared to 1 article on an average week.

MarketBeat Follows

2 people have added Ascend Wellness to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ascend Wellness insiders have not sold or bought any company stock.

Percentage Held by Insiders

21.94% of the stock of Ascend Wellness is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

17.31% of the stock of Ascend Wellness is held by institutions.

Company Calendar

• Last Earnings: 11/12/2026
• Today: 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:AAWH
• Previous Symbol: OTC:AAWH
• CIK: 1756390
• Web: www.awholdings.com
• Phone: 646-661-7600
• Fax: N/A
• Employees: 2,300
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.57)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$118.19 million
• Net Margins: -23.31%
• Pretax Margin: -16.20%
• Return on Equity: N/A
• Return on Assets: -10.85%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.66
• Quick Ratio: 0.93

Sales & Book Value

• Annual Sales: $500.58 million
• Price / Sales: 0.14
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.23) per share
• Price / Book: -1.52

Miscellaneous

• Outstanding Shares: 202,970,000
• Free Float: 158,441,000
• Market Cap: $71.04 million
• Optionable: Not Optionable
• Beta: 1.22